Giuseppe Verdile, Ph.D.
Affiliations: | School of Biomedical and Sports Science | Edith Cowan University |
Area:
Alzheimer's diseaseGoogle:
"Giuseppe Verdile"Cross-listing: Neurotree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Woodfield A, Porter T, Gilani I, et al. (2022) Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levels. Neurobiology of Aging. 114: 38-48 |
| Jayatunga DPW, Hone E, Fernando WMADB, et al. (2022) Mitoprotective Effects of a Synergistic Nutraceutical Combination: Basis for a Prevention Strategy Against Alzheimer's Disease. Frontiers in Aging Neuroscience. 13: 781468 |
| Jayatunga DPW, Hone E, Fernando WMADB, et al. (2022) A Synergistic Combination of DHA, Luteolin, and Urolithin A Against Alzheimer's Disease. Frontiers in Aging Neuroscience. 14: 780602 |
| Jayatunga DPW, Hone E, Khaira H, et al. (2021) Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease. Nutrients. 13 |
| Fernandez S, Burnham SC, Milicic L, et al. (2021) Is Associated with Amyloid-β and ε4-Related Cognitive Decline in Cognitively Normal Adults. Journal of Alzheimer's Disease Reports. 5: 111-120 |
| Moussavi Nik SH, Porter T, Newman M, et al. (2021) Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration. Journal of Alzheimer's Disease : Jad |
| Jayatunga DPW, Hone E, Bharadwaj P, et al. (2020) Targeting Mitophagy in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Pedrini S, Hone E, Gupta VB, et al. (2020) Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance. Journal of Alzheimer's Disease : Jad |
| Bharadwaj P, Solomon T, Sahoo BR, et al. (2020) Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells. Scientific Reports. 10: 10356 |
| Teimouri E, Rainey-Smith SR, Bharadwaj P, et al. (2020) Amla Therapy as a Potential Modulator of Alzheimer's Disease Risk Factors and Physiological Change. Journal of Alzheimer's Disease : Jad |